Skip to main content
SpringerLink
Log in

Jeder einzelne Risikofaktor zählt!

Effektive Schlaganfallprävention erfordert die Behandlung aller beeinflussbaren Risiken

  • Aktuelles
  • Published:
focus neurogeriatrie

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Goldstein LB, Adams R, Alberts MJ et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2006; 113: e873–e923.

    Article  PubMed  Google Scholar 

  • Cleeman JI, Grundy SM, Becker D et al. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama-Journal of the American Medical Association 2001; 285: 2486–2497.

    Article  Google Scholar 

  • Baigent C, Keech A, Kearney PM et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267–1278.

    Article  PubMed  CAS  Google Scholar 

  • Amarenco P, Bogousslavsky J, Callahan A, III et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–559.

    Article  PubMed  CAS  Google Scholar 

  • Appel LJ, Moore TJ, Obarzanek E et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 1117–1124.

    Article  PubMed  CAS  Google Scholar 

  • Sandhofer A, Iglseder B, Paulweber B, Ebenbichler CF, Patsch JR. Comparison of different definitions of the metabolic syndrome. Eur J Clin Invest 2007; 37: 109–116.

    Article  PubMed  CAS  Google Scholar 

  • Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 2005; 36: 1212–1217.

    Article  PubMed  Google Scholar 

  • Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults – findings from the Third National Health and Nutrition Examination Survey. Jama-Journal of the American Medical Association 2002; 287: 356–359.

    Article  Google Scholar 

  • Toole JF, Malinow MR, Chambless LE. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The vitamin intervention for stroke prevention (VISP) randomized controlled trial. Journal of Vascular Surgery 2004; 39: 1356.

    Article  Google Scholar 

  • Lonn E, Yusuf S, Arnold MJ et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354: 1567–1577.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Christian-Doppler-Klinik, Universitätsklinik für Geriatrie, Salzburg

    B. Iglseder

Authors
  1. B. Iglseder
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iglseder, B. Jeder einzelne Risikofaktor zählt!. focus neurogeriatrie 1, 14–15 (2007). https://doi.org/10.1007/s12151-007-0002-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12151-007-0002-9

Search

Navigation